SignalXSignalX

IOSP INNOSPEC INC.

FY2025 10-K
Filed: Feb 18, 2026
Health Care
Chemicals & Allied ProductsSEC EDGAR
INNOSPEC INC. Overview

INNOSPEC INC. (IOSP) filed its fiscal year 2025 10-K annual report with the SEC on Feb 18, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • • Core business: Specialty chemicals for Performance Chemicals, Fuel Specialties, and Oilfield Services segments globally
  • • New product emphasis: Innovations in mild surfactants, detergents, cold flow improvers, friction modifiers, biocides, and drilling mud additives
+3 more insights

Management Discussion & Analysis

  • • Revenue $1.778B, down 4% YoY; Performance Chemicals up $27.7M (4%), Fuel Specialties flat, Oilfield Services down $95.5M (19%)
  • • Operating income $129.5M vs $177.9M, operating margin 7.3% vs 9.6%; Fuel Specialties best: $144.8M (+12%), Oilfield Services worst: $23.3M (-40%)
+3 more insights

Risk Factors

  • • Regulatory risk from U.S. EPA and FAA leaded AvGas phase-out by 2030 risks loss of AvGas income
  • • Geopolitical risk from operations in Middle East, Asia-Pacific, Eastern Europe, Latin America with political instability and trade restrictions
+3 more insights

Financial Summary
XBRL

Revenue

$1.8B

Net Income

$117M

Gross Margin

27.7%

Operating Margin

7.3%

Net Margin

6.6%

ROE

8.8%

Total Assets

$1.8B

EPS (Diluted)

$4.67

Operating Cash Flow

$138M

Source: XBRL data from INNOSPEC INC. FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on INNOSPEC INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available